Detalhe da pesquisa
1.
The effect of (neo)adjuvant chemotherapy on long-term survival outcomes in patients with invasive lobular breast cancer treated with endocrine therapy: A retrospective cohort study.
Cancer
; 130(6): 927-935, 2024 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37985357
2.
Recurrent postmenopausal bleeding: Pathological findings and predictive factors. A multicenter, prospective, observational study.
Acta Obstet Gynecol Scand
; 103(7): 1283-1291, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38695570
3.
Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
Am J Obstet Gynecol
; 228(4): 440.e1-440.e20, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36403862
4.
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.
BJOG
; 130(8): 968-977, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36715559
5.
Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.
Breast Cancer Res Treat
; 194(1): 159-170, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35507134
6.
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 177(3): 723-733, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31302855
7.
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer.
Breast Cancer Res Treat
; 156(3): 557-566, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-27060914
8.
Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Int J Cancer
; 136(3): 668-77, 2015 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24947112
9.
The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.
Cancer
; 119(5): 955-62, 2013 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23165859
10.
Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort.
Cancer Med
; 12(3): 3123-3133, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36127572
11.
Expression and Localization of Ferritin-Heavy Chain Predicts Recurrence for Breast Cancer Patients with a BRCA1/2 Mutation.
Cancers (Basel)
; 16(1)2023 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38201455
12.
Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation.
J Natl Cancer Inst
; 115(11): 1318-1328, 2023 11 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37369040
13.
HER2-low breast cancer shows a lower immune response compared to HER2-negative cases.
Sci Rep
; 12(1): 12974, 2022 07 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35902644
14.
Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.
PLoS One
; 17(9): e0275015, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36137114
15.
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.
Breast
; 61: 98-107, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34929424
16.
Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
Cancers (Basel)
; 13(11)2021 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-34063736
17.
The effect of hormone therapy on breast density following risk-reducing salpingo-oophorectomy in women with an increased risk for breast and ovarian cancer.
Menopause
; 28(11): 1307-1312, 2021 08 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34374687
18.
Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study).
JMIR Res Protoc
; 10(1): e24414, 2021 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-33480862
19.
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.
Sci Rep
; 11(1): 19787, 2021 10 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34611289
20.
The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer.
Breast
; 52: 102-109, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32497987